Estudio de contactos en infectados por SARS-CoV-2. El papel fundamental de la Atención Primaria y de la Salud Pública

por Bellmunt, J.M., Caylà, J.A., Millet, J.P.
Publicado no Semergen (2020)

SEOM clinical guidelines for the treatment of renal cell carcinoma

por Bellmunt, J., Puente, J., Garcia de Muro, J., Lainez, N., Rodríguez, C., Duran, I.
Publicado no Clin Transl Oncol (2014)

Sorafenib tolerability in elderly patients with advanced renal cell carcinoma: results from a large pooled analysis

por Procopio, G, Bellmunt, J, Dutcher, J, Bracarda, S, Knox, J, Brueckner, A, Molnar, I, Escudier, B, Hutson, T E
Publicado em 2013

The impact of prior platinum therapy on survival in patients with metastatic urothelial cancer receiving vinflunine

por Harshman, L C, Fougeray, R, Choueiri, T K, Schutz, F A, Salhi, Y, Rosenberg, J E, Bellmunt, J
Publicado em 2013

Reexamining treatment of high-grade T1 bladder cancer according to depth of lamina propria invasion: a prospective trial of 200 patients

por Orsola, A, Werner, L, de Torres, I, Martin-Doyle, W, Raventos, C X, Lozano, F, Mullane, S A, Leow, J J, Barletta, J A, Bellmunt, J, Morote, J
Publicado no Br J Cancer (2015)

Mitogen-activated protein kinase phosphatase-1 (MKP-1) impairs the response to anti-epidermal growth factor receptor (EGFR) antibody cetuximab in metastatic colorectal cancer patie...

por Montagut, C, Iglesias, M, Arumi, M, Bellosillo, B, Gallen, M, Martinez-Fernandez, A, Martinez-Aviles, L, Cañadas, I, Dalmases, A, Moragon, E, Lema, L, Serrano, S, Rovira, A, Rojo, F, Bellmunt, J, Albanell, J
Publicado em 2010

Multicenter phase II study of trabectedin in patients with metastatic castration-resistant prostate cancer

por Michaelson, M. D., Bellmunt, J., Hudes, G. R., Goel, S., Lee, R. J., Kantoff, P. W., Stein, C. A., Lardelli, P., Pardos, I., Kahatt, C., Nieto, A., Cullell-Young, M., Lewis, N. L., Smith, M. R.
Publicado em 2012

Vinflunine–gemcitabine versus vinflunine–carboplatin as first-line chemotherapy in cisplatin-unfit patients with advanced urothelial carcinoma: results of an international randomiz...

por De Santis, M., Wiechno, P. J., Bellmunt, J., Lucas, C., Su, W.-C., Albiges, L., Lin, C.-C., Senkus-Konefka, E., Flechon, A., Mourey, L., Necchi, A., Loidl, W. C., Retz, M. M., Vaissière, N., Culine, S.
Publicado no Ann Oncol (2016)

Impact of the number of cycles of platinum-based first-line chemotherapy for advanced urothelial carcinoma

por Sonpavde, GP, Mariani, L, Lo Vullo, S, Raggi, D, Giannatempo, P, Bamias, A, Crabb, SJ, Bellmunt, J, Yu, EY, Niegisch, G, Vaishampayan, UN, Theodore, C, Berthold, DR, Srinivas, S, Sridhar, SS, Plimack, ER, Rosenberg, JE, Powles, T, Galsky, MD, Necchi, A
Publicado no J Urol (2018)

PD-L1 expression in nonclear-cell renal cell carcinoma

por Choueiri, T. K., Fay, A. P., Gray, K. P., Callea, M., Ho, T. H., Albiges, L., Bellmunt, J., Song, J., Carvo, I., Lampron, M., Stanton, M. L., Hodi, F. S., McDermott, D. F., Atkins, M. B., Freeman, G. J., Hirsch, M. S., Signoretti, S.
Publicado no Ann Oncol (2014)

A randomized, double-blind, placebo-controlled phase II study of maintenance therapy with tasquinimod in patients with metastatic castration-resistant prostate cancer responsive to...

por Fizazi, K, Ulys, A, Sengeløv, L, Moe, M, Ladoire, S, Thiery-Vuillemin, A, Flechon, A, Guida, A, Bellmunt, J, Climent, M A, Chowdhury, S, Dumez, H, Matouskova, M, Penel, N, Liutkauskiene, S, Stachurski, L, Sternberg, C N, Baton, F, Germann, N, Daugaard, G
Publicado no Ann Oncol (2017)

A prognostic index model for predicting overall survival in patients with metastatic castration-resistant prostate cancer treated with abiraterone acetate after docetaxel

por Chi, K. N., Kheoh, T., Ryan, C. J., Molina, A., Bellmunt, J., Vogelzang, N. J., Rathkopf, D. E., Fizazi, K., Kantoff, P. W., Li, J., Azad, A. A., Eigl, B. J., Heng, D. Y. C., Joshua, A. M., de Bono, J. S., Scher, H. I.
Publicado no Ann Oncol (2016)

Treatment of cancer with oral drugs: a position statement by the Spanish Society of Medical Oncology (SEOM)

por Colomer, R., Alba, E., González-Martin, A., Paz-Ares, L., Martín, M., Llombart, A., Rodríguez Lescure, Á., Salvador, J., Albanell, J., Isla, D., Lomas, M., Rodríguez, C. A., Trigo, J. M., Germà, J. R., Bellmunt, J., Tabernero, J., Rosell, R., Aranda, E., Cubedo, R., Baselga, J.
Publicado em 2010

Randomized phase III KEYNOTE-045 trial of pembrolizumab versus paclitaxel, docetaxel, or vinflunine in recurrent advanced urothelial cancer: results of >2 years of follow-up

por Fradet, Y, Bellmunt, J, Vaughn, D J, Lee, J L, Fong, L, Vogelzang, N J, Climent, M A, Petrylak, D P, Choueiri, T K, Necchi, A, Gerritsen, W, Gurney, H, Quinn, D I, Culine, S, Sternberg, C N, Nam, K, Frenkl, T L, Perini, R F, de Wit, R, Bajorin, D F
Publicado no Ann Oncol (2019)

Impact of contemporary patterns of chemotherapy utilization on survival in patients with advanced cancer of the urinary tract: a Retrospective International Study of Invasive/Advan...

por Bamias, A., Tzannis, K., Harshman, L.C., Crabb, S.J., Wong, Y.-N., Kumar Pal, S., De Giorgi, U., Ladoire, S., Agarwal, N., Yu, E.Y., Niegisch, G., Necchi, A., Sternberg, C.N., Srinivas, S., Alva, A., Vaishampayan, U., Cerbone, L., Liontos, M., Rosenberg, J., Powles, T., Bellmunt, J., Galsky, M.D.
Publicado no Ann Oncol (2018)

Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma

por Bellmunt, J., de Wit, R., Vaughn, D.J., Fradet, Y., Lee, J.-L., Fong, L., Vogelzang, N.J., Climent, M.A., Petrylak, D.P., Choueiri, T.K., Necchi, A., Gerritsen, W., Gurney, H., Quinn, D.I., Culine, S., Sternberg, C.N., Mai, Y., Poehlein, C.H., Perini, R.F., Bajorin, D.F.
Publicado no N Engl J Med (2017)

Nomogram-based prediction of overall survival in patients with metastatic urothelial carcinoma receiving first-line platinum-based chemotherapy: Retrospective International Study o...

por Necchi, A, Sonpavde, G, Lo Vullo, S, Giardiello, D, Bamias, A, Crabb, SJ, Harshman, LC, Bellmunt, J, De Giorgi, U, Sternberg, CN, Cerbone, L, Ladoire, S, Wong, Y-N, Yu, EY, Chowdhury, S, Niegisch, G, Srinivas, S, Vaishampayan, UN, Pal, SK, Agarwal, N, Alva, A, Baniel, J, Golshayan, A, Morales-Barrera, R, Bowles, DW, Milowsky, MI, Theodore, C, Berthold, RD, Daugaard, G, Sridhar, SS, Powles, T, Rosenberg, JE, Galsky, MD, Mariani, L
Publicado no Eur Urol (2016)

Robot-assisted versus open radical cystectomy in patients receiving perioperative chemotherapy for muscle-invasive bladder cancer: the oncologists’ perspective from a multicentre s...

por Necchi, A, Pond, GR, Smaldone, MC, Pal, SK, Chan, K, Wong, YN, Viterbo, R, Sonpavde, G, Harshman, LC, Crabb, S, Alva, A, Chowdhury, S, De Giorgi, U, Srinivas, S, Agarwal, N, Bamias, A, Baniel, J, Golshayan, A, Ladoire, S, Sternberg, CN, Cerbone, L, Yu, EY, Bellmunt, J, Vaishampayan, U, Niegisch, G, Hussain, S, Bowles, DW, Morales-Barrera, R, Milowsky, MI, Theodore, C, Berthold, RD, Sridhar, SS, Powles, T, Rosenberg, JE, Galsky, MD
Publicado no Eur Urol Focus (2017)

Biochemical markers of bone turnover and clinical outcome in patients with renal cell and bladder carcinoma with bone metastases following treatment with zoledronic acid: The TUGAM...

por Alcaraz, A, González-López, R, Morote, J, de la Piedra, C, Meseguer, C, Esteban, E, Climent, M, González-Gragera, B, Álvarez-Ossorio, J-L, Chirivella, I, Mellado, B, Lara, P-C, Vázquez, F, Contreras, J-A, Carles, J, Murias, A, Calderero, V, Comet-Batlle, J, González-del Alba, A, León-Mateos, L, Mañas, A, Segarra, J, Lassa, A, González-Enguita, C, Méndez, M-J, Samper, P, Unda, M, Mahillo-Fernández, I, Bellmunt, J
Publicado em 2013

Lack of effectiveness of postchemotherapy lymphadenectomy in bladder cancer patients with clinical evidence of metastatic pelvic or retroperitoneal lymph nodes only: a propensity s...

por Necchi, A, Mariani, L, Vullo, S Lo, Yu, EY, Woods, ME, Wong, YN, Harshman, LC, Alva, A, Sternberg, CN, Bamias, A, Grivas, P, Koshkin, VS, Roghmann, F, Dobruch, J, Eigl, BJ, Nappi, L, Milowsky, MI, Niegisch, G, Pal, SK, De Giorgi, U, Recine, F., Vaishampayan, U, Berthold, RD, Bowles, DW, Baniel, J, Theodore, C, Ladoire, S, Srinivas, S, Agarwal, N, Crabb, S, Sridhar, SS, Golshayan, A, Ohlmann, C, Xylinas, E, Powles, T, Rosenberg, J, Bellmunt, J, van Rhijn, B, Galsky, MD, Hendricksen, K
Publicado no Eur Urol Focus (2017)